The meeting was originally scheduled for Dec. 12 and has been re-scheduled by the FDA because they were unable to complete their internal review of the PMA data in time.
The Superion Interspinous Spacer System is a minimally invasive spinal implant designed to treat moderate lumbar spinal stenosis. The device received the CE Mark in 2007 and has been implanted in more than 2,000 patients worldwide.
More articles on devices:
IlluminOss Medical gets 2 new patents — 5 quick facts
Oxford Performance Materials launches 3D printing technology for aerospace & industrial applications
Will Thomas Sullivan serve on Span-America Medical Systems’ board of directors? 4 quick facts
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
